Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Management of Patients Diagnosed with Endometrial Hyperplasia: Comparison of Guidelines.

Cancers·2026
Same author

Paraneoplastic Neurological Syndromes in Ovarian Cancer: Case Report and Narrative Review for Diagnostic and Clinical Implications.

Healthcare (Basel, Switzerland)·2026
Same author

Sentinel lymph node biopsy in vulvar cancer: current evidence, limitations, and future perspectives.

Journal of gynecologic oncology·2026
Same author

Outcomes of node-positive cervical cancer treated with neoadjuvant chemotherapy followed by radical surgery: a single-center approach to a challenging disease.

Journal of gynecologic oncology·2026
Same author

Alignment of Molecular Classification Between Diagnosis and Recurrence in Endometrial Cancer: Lessons from a Single-Institution Experience to Inform Future Pathways.

Cancers·2026
Same author

A pilot multimodal study of cervical cancer: Raman spectroscopy as a molecular fingerprint tool.

PloS one·2026

相关实验视频

Updated: Jun 21, 2026

Multispectral Real-time Fluorescence Imaging for Intraoperative Detection of the Sentinel Lymph Node in Gynecologic Oncology
06:37

Multispectral Real-time Fluorescence Imaging for Intraoperative Detection of the Sentinel Lymph Node in Gynecologic Oncology

Published on: October 20, 2010

23.3K

在子宫内膜癌中的哨戒节点映射.

Giorgio Bogani1,2, Andrea Giannini3, Enrico Vizza4

  • 1Gynecological Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milano, Italy.

Journal of gynecologic oncology
|November 16, 2023
PubMed
概括

哨兵节点映射准确地识别早期子宫内膜癌的节点状态,比传统的淋巴切除术更好地检测低体积疾病,而不会增加手术风险.

关键词:
淋巴结是指淋巴结中的一个.子宫新生体子宫新生体.

更多相关视频

The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy
07:51

The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy

Published on: June 1, 2019

19.5K
Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
05:52

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Published on: August 19, 2021

11.5K

相关实验视频

Last Updated: Jun 21, 2026

Multispectral Real-time Fluorescence Imaging for Intraoperative Detection of the Sentinel Lymph Node in Gynecologic Oncology
06:37

Multispectral Real-time Fluorescence Imaging for Intraoperative Detection of the Sentinel Lymph Node in Gynecologic Oncology

Published on: October 20, 2010

23.3K
The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy
07:51

The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy

Published on: June 1, 2019

19.5K
Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
05:52

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Published on: August 19, 2021

11.5K

科学领域:

  • 妇科瘤学 妇科瘤学
  • 手术病理学手术病理学

背景情况:

  • 节点状况是早期子宫内膜癌的关键预后因素.
  • 由于与淋巴切除术相关的并发症,逆腺体分期的实用性受到争议.
  • 哨兵节点映射提供了一种不那么侵入性的方法来评估节点参与.

研究的目的:

  • 评估哨兵节点测绘作为淋巴切除术的替代方案,用于在子宫内膜癌中测定结节阶段.
  • 为了确定哨兵节点映射是否可以准确地识别患有节点疾病的患者,包括微转移.

主要方法:

  • 哨兵节点映射涉及去除排水子宫的第一个淋巴结.
  • 对哨兵节点进行彻底的超级测试,以检测最小的疾病.
  • 哨兵节点测绘与常规淋巴切除术在识别结节转移中的比较.

主要成果:

  • 在检测节点疾病方面,哨兵节点测绘与淋巴结除术并没有劣势.
  • 超级增长的哨兵节点增加了低体积疾病 (微转移,孤立的瘤细胞) 的识别.
  • 与淋巴结切除术相比,哨兵节点映射实现了较高的结节疾病识别率.

结论:

  • 哨兵节点映射是早期子宫内膜癌中节点分期的可靠方法,改善了最小疾病的检测.
  • 这种技术可以提供预后数据,而不会增加全淋巴切除术的发病率.
  • 对针对低体积结节疾病患者的分子特征量身定制的辅助疗法需要进一步研究.